 | • レポートコード：GIR-107A14594 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、顆粒球マクロファージコロニー刺激因子（GM-CSF）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。顆粒球マクロファージコロニー刺激因子（GM-CSF）の種類別市場規模（CG-0070、Gimsilumab、GSK-3196165、Lenzilumab、MGN-1601、その他）、用途別市場規模（固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・顆粒球マクロファージコロニー刺激因子（GM-CSF）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aduro BioTech Inc、Amgen Inc、BriaCell Therapeutics Corp、Cold Genesys Inc、GlaxoSmithKline Plc、Humanigen Inc、Mologen AG、Morphotek Inc、Sillajen Biotherapeutics、Takeda Pharmaceutical Co Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CG-0070、Gimsilumab、GSK-3196165、Lenzilumab、MGN-1601、その他 ・用途別分析2016年-2026年：固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他 ・顆粒球マクロファージコロニー刺激因子（GM-CSF）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・顆粒球マクロファージコロニー刺激因子（GM-CSF）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・顆粒球マクロファージコロニー刺激因子（GM-CSF）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・顆粒球マクロファージコロニー刺激因子（GM-CSF）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・顆粒球マクロファージコロニー刺激因子（GM-CSF）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Granulocyte Macrophage Colony Stimulating Factor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Granulocyte Macrophage Colony Stimulating Factor size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Granulocyte Macrophage Colony Stimulating Factor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Granulocyte Macrophage Colony Stimulating Factor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market segment by Application can be divided into
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
The key market players for global Granulocyte Macrophage Colony Stimulating Factor market are listed below:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Granulocyte Macrophage Colony Stimulating Factor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Granulocyte Macrophage Colony Stimulating Factor, with price, sales, revenue and global market share of Granulocyte Macrophage Colony Stimulating Factor from 2019 to 2021.
Chapter 3, the Granulocyte Macrophage Colony Stimulating Factor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Granulocyte Macrophage Colony Stimulating Factor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Granulocyte Macrophage Colony Stimulating Factor market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Granulocyte Macrophage Colony Stimulating Factor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Granulocyte Macrophage Colony Stimulating Factor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 CG-0070
1.2.3 Gimsilumab
1.2.4 GSK-3196165
1.2.5 Lenzilumab
1.2.6 MGN-1601
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size & Forecast
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Value (2016-2026))
1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume (2016-2026)
1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity Analysis
1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Total Production Capacity (2016-2026)
1.5.2 Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Granulocyte Macrophage Colony Stimulating Factor Market Drivers
1.6.2 Granulocyte Macrophage Colony Stimulating Factor Market Restraints
1.6.3 Granulocyte Macrophage Colony Stimulating Factor Trends Analysis
2 Manufacturers Profiles
2.1 Aduro BioTech Inc
2.1.1 Aduro BioTech Inc Details
2.1.2 Aduro BioTech Inc Major Business
2.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen Inc
2.2.1 Amgen Inc Details
2.2.2 Amgen Inc Major Business
2.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 BriaCell Therapeutics Corp
2.3.1 BriaCell Therapeutics Corp Details
2.3.2 BriaCell Therapeutics Corp Major Business
2.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cold Genesys Inc
2.4.1 Cold Genesys Inc Details
2.4.2 Cold Genesys Inc Major Business
2.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GlaxoSmithKline Plc
2.5.1 GlaxoSmithKline Plc Details
2.5.2 GlaxoSmithKline Plc Major Business
2.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Humanigen Inc
2.6.1 Humanigen Inc Details
2.6.2 Humanigen Inc Major Business
2.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Mologen AG
2.7.1 Mologen AG Details
2.7.2 Mologen AG Major Business
2.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.7.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Morphotek Inc
2.8.1 Morphotek Inc Details
2.8.2 Morphotek Inc Major Business
2.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Sillajen Biotherapeutics
2.9.1 Sillajen Biotherapeutics Details
2.9.2 Sillajen Biotherapeutics Major Business
2.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Takeda Pharmaceutical Co Ltd
2.10.1 Takeda Pharmaceutical Co Ltd Details
2.10.2 Takeda Pharmaceutical Co Ltd Major Business
2.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product and Services
2.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturer
3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Granulocyte Macrophage Colony Stimulating Factor
3.4 Market Concentration Rate
3.4.1 Top 3 Granulocyte Macrophage Colony Stimulating Factor Manufacturer Market Share
3.4.2 Top 6 Granulocyte Macrophage Colony Stimulating Factor Manufacturer Market Share
3.5 Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Granulocyte Macrophage Colony Stimulating Factor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Region
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Region (2016-2026)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2016-2026)
4.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026)
4.3 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026)
4.4 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026)
4.5 South America Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026)
4.6 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Type (2016-2026)
5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2016-2026)
5.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Application (2016-2026)
6.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2016-2026)
6.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2026)
7.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2026)
7.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
7.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Country (2016-2026)
7.3.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2026)
8.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2026)
8.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
8.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Country (2016-2026)
8.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2026)
9.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2026)
9.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size by Region
9.3.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2026)
10.2 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2026)
10.3 South America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
10.3.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Country (2016-2026)
10.3.2 South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2026)
11.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2026)
11.3 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
11.3.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Granulocyte Macrophage Colony Stimulating Factor Typical Distributors
12.3 Granulocyte Macrophage Colony Stimulating Factor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application, (USD Million), 2021-2026
Table 3. Aduro BioTech Inc Basic Information, Manufacturing Base and Competitors
Table 4. Aduro BioTech Inc Major Business
Table 5. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 6. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc Major Business
Table 9. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 10. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. BriaCell Therapeutics Corp Basic Information, Manufacturing Base and Competitors
Table 12. BriaCell Therapeutics Corp Major Business
Table 13. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 14. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cold Genesys Inc Basic Information, Manufacturing Base and Competitors
Table 16. Cold Genesys Inc Major Business
Table 17. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 18. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Plc Major Business
Table 21. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 22. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Humanigen Inc Basic Information, Manufacturing Base and Competitors
Table 24. Humanigen Inc Major Business
Table 25. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 26. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mologen AG Basic Information, Manufacturing Base and Competitors
Table 28. Mologen AG Major Business
Table 29. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 30. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Morphotek Inc Basic Information, Manufacturing Base and Competitors
Table 32. Morphotek Inc Major Business
Table 33. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 34. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sillajen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 36. Sillajen Biotherapeutics Major Business
Table 37. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 38. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Takeda Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Pharmaceutical Co Ltd Major Business
Table 41. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product and Services
Table 42. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 44. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Granulocyte Macrophage Colony Stimulating Factor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Granulocyte Macrophage Colony Stimulating Factor Production Site of Key Manufacturer
Table 48. Granulocyte Macrophage Colony Stimulating Factor New Entrant and Capacity Expansion Plans
Table 49. Granulocyte Macrophage Colony Stimulating Factor Mergers & Acquisitions in the Past Five Years
Table 50. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2016-2021e) & (K Pcs)
Table 51. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026) & (K Pcs)
Table 52. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 55. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 56. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2016-2021e) & (USD/Pcs)
Table 59. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2026) & (USD/Pcs)
Table 60. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 61. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 62. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2016-2021e) & (USD/Pcs)
Table 65. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2026) & (USD/Pcs)
Table 66. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2016-2021e) & (K Pcs)
Table 67. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Pcs)
Table 68. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 71. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 72. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 73. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 74. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2016-2021e) & (K Pcs)
Table 75. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Pcs)
Table 76. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 79. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 80. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 81. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2016-2021e) & (K Pcs)
Table 83. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 90. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2016-2021e) & (K Pcs)
Table 91. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Pcs)
Table 92. South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 95. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 96. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 97. South America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2016-2021e) & (K Pcs)
Table 99. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Pcs)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Granulocyte Macrophage Colony Stimulating Factor Typical Distributors
Table 109. Granulocyte Macrophage Colony Stimulating Factor Typical Customers
List of Figures
Figure 1. Granulocyte Macrophage Colony Stimulating Factor Picture
Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2020
Figure 3. CG-0070
Figure 4. Gimsilumab
Figure 5. GSK-3196165
Figure 6. Lenzilumab
Figure 7. MGN-1601
Figure 8. Others
Figure 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2020
Figure 10. Solid Tumor
Figure 11. Lymphoma
Figure 12. Kidney Cancer
Figure 13. Lung Disease
Figure 14. Others
Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Sales (2016-2026) & (K Pcs)
Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Granulocyte Macrophage Colony Stimulating Factor Market Drivers
Figure 22. Granulocyte Macrophage Colony Stimulating Factor Market Restraints
Figure 23. Granulocyte Macrophage Colony Stimulating Factor Market Trends
Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturer in 2020
Figure 25. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Manufacturer in 2020
Figure 26. Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Granulocyte Macrophage Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Granulocyte Macrophage Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2016-2026)
Figure 31. North America Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 32. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 34. South America Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 36. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 37. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2016-2026)
Figure 38. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 40. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2016-2026)
Figure 41. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 43. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 44. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 45. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 46. United States Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 50. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 51. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 52. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 53. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2016-2026)
Figure 62. China Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 69. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 70. South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 71. South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の抗血友病因子・フォンウィルブランド因子複合体市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor & von Willebrand Factor Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 世界の抗血友病因子（組換え）市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のトランスフォーミング増殖因子β2市場 2021：企業別、地域別、種類・用途別 The Transforming Growth Factor Beta 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の線維芽細胞成長因子2市場 2021：企業別、地域別、種類・用途別 The Fibroblast Growth Factor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のがんサポーティブケア薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Cancer Supportive Care Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…